Prof. Hongli Liu 刘红利
Chief Physician, Professor
Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Comprehensive and individualized chemotherapy and radiotherapy for digestive system tumors, especially colorectal, gastric, and esophageal cancers. Expertise includes preoperative staging, treatment decision-making, postoperative care, and management of precancerous lesions.
Dr. Liu is a Professor and Chief Physician leading the Abdominal Tumor Ward II at Union Hospital. A key member of the gastrointestinal tumor MDT team, Dr. Liu focuses on clinical trials and translational research. Dr. Liu has led or participated in over 10 research projects and published more than 30 academic papers, including over 15 SCI-indexed articles.
Professional roles
- Standing Committee Member, Precision Medicine and Tumor MDT Professional Committee, Chinese Research Hospital Association
- Member, Colorectal Cancer Professional Committee, China South Oncology Clinical Research Association (CSWOG-CRC)
- Vice Chair, Youth Committee, Hubei Anti-Cancer Association
- Member, Lymphoma Professional Committee, Hubei Anti-Cancer Association
Name order: in Chinese the family name comes first (Liu Hongli). Papers usually list the name as Hongli Liu or Liu H.
Selected publications
84 papers on PubMed matched by name and affiliation; 19 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cancer Manag Res, 2026 (senior author): Research Progress on the Relationship Between Radiation Enteritis and Gut Microbiota Dysbiosis. PubMed 42703569
- BMC Gastroenterol, 2026 (senior author): Association of gut Fusobacteria abundance with peritoneal metastasis in gastric signet-ring cell carcinoma: a cross-sectional study. PubMed 42928123
- Front Pharmacol, 2026 (senior author): Gut microbiome components predict response to neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy in locally advanced rectal cancer (UNION): a prospective study. PubMed 42292847
- Front Oncol, 2026 (senior author): Undifferentiated pleomorphic sarcoma as a rare extracolonic manifestation in Lynch syndrome with MLH1 germline mutation: a case report. PubMed 42094191
- Cancer Manag Res, 2026 (senior author): Preoperative Prognostic Factors of Colorectal Cancer in Patients from Central China: A Retrospective Observational Study. PubMed 41982702
- Mol Nutr Food Res, 2026 (senior author): L-Arginine in Cancer Immunity and Therapy. PubMed 41860423
- J Immunother Cancer, 2025 (senior author): Effect of radiotherapy exposure on fruquintinib plus sintilimab treatment in refractory microsatellite stable metastatic colorectal cancer: a prospective observation study. PubMed 39755582
- Cancers (Basel), 2024 (senior author): Gastrointestinal Microbiota in Gastric Cancer: Potential Mechanisms and Clinical Applications-A Literature Review. PubMed 39456641
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion